These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16080511)

  • 1. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
    Sesterhenn AM; Mandic R; Dünne AA; Werner JA
    Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular assay to detect metastatic head and neck squamous cell carcinoma.
    Becker MT; Shores CG; Yu KK; Yarbrough WG
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):21-7. PubMed ID: 14732763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells.
    Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G
    Head Neck; 2004 Jun; 26(6):494-503. PubMed ID: 15162350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas.
    Capouillez A; Debauve G; Decaestecker C; Filleul O; Chevalier D; Mortuaire G; Coppée F; Leroy X; Belayew A; Saussez S
    Histopathology; 2009 Jul; 55(1):77-90. PubMed ID: 19614770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract.
    Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA
    Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
    Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
    Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
    Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
    Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma.
    Shores CG; Yin X; Funkhouser W; Yarbrough W
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):937-42. PubMed ID: 15313863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial cell nicotinic acetylcholine receptor expression in head and neck squamous cell carcinoma pathogenesis.
    Carracedo DG; Rodrigo JP; Nieto CS; Gonzalez MV
    Anticancer Res; 2007; 27(2):835-9. PubMed ID: 17465209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
    Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
    Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry.
    Garrel R; Dromard M; Costes V; Barbotte E; Comte F; Gardiner Q; Cartier C; Makeieff M; Crampette L; Guerrier B; Boulle N
    Clin Cancer Res; 2006 Apr; 12(8):2498-505. PubMed ID: 16638858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5.
    McDonald LA; Walker DM; Gibbins JR
    Oral Oncol; 1998 Jul; 34(4):276-83. PubMed ID: 9813723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
    Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
    Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
    Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
    Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.